Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
Does Ketamine-Midazolam have a better efficacy and safety profile compared to Midazolam -
Pethidine in Endoscopic Retrograde Cholangiopancreatography (ERCP)?